jRCTs051240012招募中不适用
Efficacy of emulsion with anti-Staphylococcus aureus ostrich antibody for atopic dermatitis (EASII Study)
未提供0 个研究点目标入组 10 人开始时间: 2024年6月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 10
- 主要终点
- Eczema Area and Severity Index (EASI) score
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Single Blind
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •Patients with atopic dermatitis receiving therapy with dupilumab for 16 weeks
- •Patients who having treatment-resistant bisymmetric lesion evaluated the same grade severity (four categories: mild, moderate, severe, most severe) with Eczema Area and Severity Index (EASI) score in local lesion
- •Patients who are 18 years old and more at informed consent
- •Patients who is eligible to agree with consent form
排除标准
- •Patients determined ineligible to participate by principal investigator or sub investigator
结局指标
主要结局
Eczema Area and Severity Index (EASI) score
时间窗: 4 weeks after started the treatment
Rates of change from baseline to 4 weeks after started the treatment at Eczema Area and Severity Index (EASI) score in local lesion
次要结局
- EASI score in local lesion(2 weeks)
- Numerical Rating Scale score(2 or 4 weeks)
- The Patient Oriented Eczema Measure score(2 or 4 weeks)
研究者
相似试验
招募中
不适用
ACE study (ACE study)Gastric adenoma or early gastric cancer that is an absolute indication for ESD.jRCT103224050764
招募中
不适用
EVERIMEN Study (EVERIMEN Study)androgenetic alopeciajRCTs05124030310
招募中
不适用
ESFstudy (ESFstudy)IFALDjRCTs03124043615
招募中
不适用
TAKUMI study (TAKUMI study)Congenital hemophilia AjRCT1030240076Chugai Pharmaceutical Co., Ltd.100
招募中
不适用
EDEN studyCKD with DyslipidemiajRCTs05124026220